Clinical Trial Update: A Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study in healthy Korean male volunteers evaluating Lozanoc and Sporanox has completed. Sponsor: Boryung Pharmaceutical Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis
• Dermatomycoses
• Histoplasmosis
• Superficial Mycoses

Drugs mentioned

• Lozanoc
• SPORANOX (Itraconazole)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Superficial Mycoses, Dermatomycoses | Phase 1 | Status: COMPLETED